Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nuria Mederos

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Revue Medicale Suisse|May 17, 2024
[Management of bone metastasis in non-small cell lung cancer]Aikaterini Apeiranthiti, Fleur Vanniere, Karim Bayoumy, et al.
Journal of Thoracic Disease|March 12, 2026
The value of positron emission tomography scan in predicting pathologic response of non-small cell lung cancer managed by neoadjuvant chemo-immunotherapyLouis-Emmanuel Chriqui, Maged Zaher, Etienne Abdelnour-Berchtold, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 22, 2023
Development of an eHealth-enhanced model of care for the monitoring and management of immune-related adverse events in patients treated with immune checkpoint inhibitorsAndré Manuel da Silva Lopes, Sara Colomer-Lahiguera, Célia Darnac, et al.
Journal of Translational Medicine|September 29, 2011
mRNA expression levels and genetic status of genes involved in the EGFR and NF-κB pathways in metastatic non-small-cell lung cancer patientsMariacarmela Santarpia, Ignacio Magri, Maria Sanchez-Ronco, et al.
JMIR Research Protocols|October 18, 2023
Testing a Model of Care for Patients on Immune Checkpoint Inhibitors Based on Electronic Patient-Reported Outcomes: Protocol for a Randomized Phase II Controlled TrialAndré Manuel da Silva Lopes, Sara Colomer-Lahiguera, Célia Darnac, et al.
Revue Medicale Suisse|May 15, 2025
[Adverse effects of new therapeutic approaches in thoracic oncology]Almaz Sammya, Clément Normand, Nicolas Desbaillets, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|January 28, 2026
Real-world outcomes of stage III NSCLCs managed by surgery or definitive radiation therapy in the era of immunotherapyEtienne Abdelnour-Berchtold, Louis-Emmanuel Chriqui, Laetitia Zermatten, et al.
Revue Medicale Suisse|January 22, 2020
[Advances in Oncology 2019]Anastasia Vernadou, Nabila Ferahta, Nuria Mederos, et al.
European Journal of Cancer (Oxford, England : 1990)|September 18, 2021
Patient-reported outcomes for monitoring symptomatic toxicities in cancer patients treated with immune-checkpoint inhibitors: A Delphi studyAndré Manuel Da Silva Lopes, Sara Colomer-Lahiguera, Nuria Mederos Alfonso, et al.
Revue Medicale Suisse|February 2, 2022
[2021 Oncology update]May-Lucie Meyer, Konstantina Chrysou, Antonia Stamatiou, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Revue Medicale Suisse|May 17, 2024
[Management of bone metastasis in non-small cell lung cancer]Aikaterini Apeiranthiti, Fleur Vanniere, Karim Bayoumy, et al.
Journal of Thoracic Disease|March 12, 2026
The value of positron emission tomography scan in predicting pathologic response of non-small cell lung cancer managed by neoadjuvant chemo-immunotherapyLouis-Emmanuel Chriqui, Maged Zaher, Etienne Abdelnour-Berchtold, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 22, 2023
Development of an eHealth-enhanced model of care for the monitoring and management of immune-related adverse events in patients treated with immune checkpoint inhibitorsAndré Manuel da Silva Lopes, Sara Colomer-Lahiguera, Célia Darnac, et al.
Journal of Translational Medicine|September 29, 2011
mRNA expression levels and genetic status of genes involved in the EGFR and NF-κB pathways in metastatic non-small-cell lung cancer patientsMariacarmela Santarpia, Ignacio Magri, Maria Sanchez-Ronco, et al.
JMIR Research Protocols|October 18, 2023
Testing a Model of Care for Patients on Immune Checkpoint Inhibitors Based on Electronic Patient-Reported Outcomes: Protocol for a Randomized Phase II Controlled TrialAndré Manuel da Silva Lopes, Sara Colomer-Lahiguera, Célia Darnac, et al.
Revue Medicale Suisse|May 15, 2025
[Adverse effects of new therapeutic approaches in thoracic oncology]Almaz Sammya, Clément Normand, Nicolas Desbaillets, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|January 28, 2026
Real-world outcomes of stage III NSCLCs managed by surgery or definitive radiation therapy in the era of immunotherapyEtienne Abdelnour-Berchtold, Louis-Emmanuel Chriqui, Laetitia Zermatten, et al.
Revue Medicale Suisse|January 22, 2020
[Advances in Oncology 2019]Anastasia Vernadou, Nabila Ferahta, Nuria Mederos, et al.
European Journal of Cancer (Oxford, England : 1990)|September 18, 2021
Patient-reported outcomes for monitoring symptomatic toxicities in cancer patients treated with immune-checkpoint inhibitors: A Delphi studyAndré Manuel Da Silva Lopes, Sara Colomer-Lahiguera, Nuria Mederos Alfonso, et al.
Revue Medicale Suisse|February 2, 2022
[2021 Oncology update]May-Lucie Meyer, Konstantina Chrysou, Antonia Stamatiou, et al.
Pageof 3